SHP-1 (PTP1C, SH-PTP1, SHP, HCP) and SHP-2 (PTP2C, SH-PTP-2, PTP1D, Syp, SH-PTP-3) are two SH2 domain containing protein tyrosine phosphatases (PTPs) which have crucial roles in signal transduction. The goal of this study is to investigate the role of these enzymes in the signaling of platelet derived growth factor (PDGF). The experimental approach is to co-express transiently the PDGF receptor with native, truncated, mutated, chimeric, and hybrid forms of the enzymes in a well established 293 cell expression system. Such gene manipulations are intended to change the activity, substrate specificity, regulation, ability to interact with other proteins, and localization of SHP-1 and SHP-2. The objectives are to determine the effects of such altered PTP expressions on tyrosine phosphorylation of the PDGF receptor and on activation of the Ras/MAP kinase and JAK-STAT signaling pathways. By correlating activity of the PTPs, tyrosine phosphorylation of the PDGF receptor and activation of MAP kinase STATs, the intent is to obtain a better understanding of the regulatory mechanism of SHP-1 and SHP-2, better define the distinct functions of the enzymes, delineate the roles of individual phosphorylation sites of PDGF-R and proteins recruited to the sites, and produce more complete diagrams for the two major signal transduction pathways.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL057393-01A1
Application #
2397065
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1997-08-01
Project End
2001-06-30
Budget Start
1997-08-01
Budget End
1998-06-30
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Zhao, Runxiang; Fu, Xueqi; Teng, Lirong et al. (2003) Blocking the function of tyrosine phosphatase SHP-2 by targeting its Src homology 2 domains. J Biol Chem 278:42893-8
Wu, Chengyu; Guan, Qin; Wang, Yingjian et al. (2003) SHP-1 suppresses cancer cell growth by promoting degradation of JAK kinases. J Cell Biochem 90:1026-37
Zhao, Runxiang; Zhao, Zhizhuang Joe (2003) Identification of a variant form of PZR lacking immunoreceptor tyrosine-based inhibitory motifs. Biochem Biophys Res Commun 303:1028-33
Zhao, Runxiang; Guerrah, Abdelmadjid; Tang, Hua et al. (2002) Cell surface glycoprotein PZR is a major mediator of concanavalin A-induced cell signaling. J Biol Chem 277:7882-8
Xu, Ming-jiang; Zhao, Runxiang; Cao, Hongxi et al. (2002) SPAP2, an Ig family receptor containing both ITIMs and ITAMs. Biochem Biophys Res Commun 293:1037-46
Qi, Ying; Zhao, Runxiang; Cao, Hongxi et al. (2002) Purification and characterization of protein tyrosine phosphatase PTP-MEG2. J Cell Biochem 86:79-89
Xiong, Huaqi; Chen, Yongxiong; Yi, Yajun et al. (2002) A novel gene encoding a TIG multiple domain protein is a positional candidate for autosomal recessive polycystic kidney disease. Genomics 80:96-104
Mishra, Ashwini K; Zhang, Aihua; Niu, Tianqi et al. (2002) Substrate specificity of protein tyrosine phosphatase: differential behavior of SHP-1 and SHP-2 towards signal regulation protein SIRPalpha1. J Cell Biochem 84:840-6
Yang, J; Niu, T; Zhang, A et al. (2001) Relation between the flexibility of the WPD loop and the activity of the catalytic domain of protein tyrosine phosphatase SHP-1. J Cell Biochem 84:47-55
Zhao, R; Qi, Y; Chen, J et al. (2001) FYVE-DSP2, a FYVE domain-containing dual specificity protein phosphatase that dephosphorylates phosphotidylinositol 3-phosphate. Exp Cell Res 265:329-38

Showing the most recent 10 out of 31 publications